PitchCentric
AGG Talks: Government Insight for Life Sciences Leaders Podcast Series podcast artwork

business

AGG Talks: Government Insight for Life Sciences Leaders Podcast Series

Hosted by Arnall Golden Gregory LLP · business · EN-US · 13 episodes

Audience: 2

About this Podcast:

Our podcast series hosts strategic conversations at the center of life sciences, law, and policy. During each episode, AGG’s former government attorneys bring firsthand knowledge and updates from their respective agencies — such as the HHS and DOJ — and examine how the latest regulatory developments and enforcement trends impact life sciences organizations. These insider insights, paired with the practical experience of AGG’s Life Sciences team, offer the life sciences industry a map of the road ahead in today’s regulatory environment.

Pitch Analysis

Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.

Contact path

Public web form

Booking probability

17%

Guest openness

Selective

80/100
Required Score

Sign up to generate a grounded pitch for AGG Talks: Government Insight for Life Sciences Leaders Podcast Series.

Signup to Generate a Pitch

Questions about AGG Talks: Government Insight for Life Sciences Leaders Podcast Series

What is AGG Talks: Government Insight for Life Sciences Leaders Podcast Series about?

Our podcast series hosts strategic conversations at the center of life sciences, law, and policy. During each episode, AGG’s former government attorneys bring firsthand knowledge and updates from their respective agencies, such as the HHS and DOJ, and examine how the latest regulatory developments and enforcement trends impact life sciences organizations.

Who hosts AGG Talks: Government Insight for Life Sciences Leaders Podcast Series?

AGG Talks: Government Insight for Life Sciences Leaders Podcast Series is hosted by Arnall Golden Gregory LLP. The show has published 13 episodes to date.

What has AGG Talks: Government Insight for Life Sciences Leaders Podcast Series covered recently?

Recent episodes include "Patient Assistance Programs and the False Claims Act: Enforcement Trends and Compliance Risks for Life Sciences Companies" (14 January 2026, 23 minutes), "How Medicare Regulations Could Affect Access to Gender-Affirming Care: Implications for Life Sciences Companies" (14 November 2025, 17 minutes), and "DOJ’s Shifting Enforcement: CPB Disbanding, Counterfeit Drug Focus, and Gender-Affirming Care Investigations" (7 October 2025, 17 minutes).

How often does AGG Talks: Government Insight for Life Sciences Leaders Podcast Series publish?

AGG Talks: Government Insight for Life Sciences Leaders Podcast Series publishes roughly every few months, with episodes averaging 23 minutes across 13 episodes.

How hard is it to get booked on AGG Talks: Government Insight for Life Sciences Leaders Podcast Series?

Booking probability for AGG Talks: Government Insight for Life Sciences Leaders Podcast Series is 17%, and the host is rated Selective on guests. AGG Talks: Government Insight for Life Sciences Leaders Podcast Series requires a Pod Score of 80 or higher. AGG Talks: Government Insight for Life Sciences Leaders Podcast Series's contact route on record: public web form.

Who should pitch AGG Talks: Government Insight for Life Sciences Leaders Podcast Series?

The strongest fits for AGG Talks: Government Insight for Life Sciences Leaders Podcast Series are Pharmaceuticals. AGG Talks: Government Insight for Life Sciences Leaders Podcast Series has a business audience.

About the host

Arnall Golden Gregory LLP hosts AGG Talks: Government Insight for Life Sciences Leaders Podcast Series, a business show with 13 episodes published.

Host email not verified for this showSign in to unlock →

Recent episodes

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

  • AGG Talks: Government Insight for Life Sciences Leaders Podcast Series

    Patient Assistance Programs and the False Claims Act: Enforcement Trends and Compliance Risks for Life Sciences Companies

    Jan 14, 202623 minS0

    <p>In this episode, AGG Life Sciences co-chair Alan Minsk is joined by AGG Healthcare and Life Sciences partner David Blank, former Senior Counsel at the HHS Office of Inspector General ("OIG"), for an in-depth...

  • Episode #3

    How Medicare Regulations Could Affect Access to Gender-Affirming Care: Implications for Life Sciences Companies

    Nov 14, 202517 minS2

    <p>In this episode, AGG Life Sciences co-chair Alan Minsk and Healthcare partner Andrew Tsui examine how the Centers for Medicare & Medicaid Services ("CMS") may apply the Medicare Conditions of Participation ("COPs")...

  • Episode #2

    DOJ’s Shifting Enforcement: CPB Disbanding, Counterfeit Drug Focus, and Gender-Affirming Care Investigations

    Oct 7, 202517 minS2

    <p>In this episode, Alan Minsk, AGG Food & Drug practice chair and Life Sciences co-chair, and Gabe Scannapieco, Litigation and Healthcare partner and Life Sciences co-chair, unpack recent shifts at the U.S. Department...

  • Episode #1

    HHS Policy Changes, Supreme Court Rulings, and the DOJ-HHS False Claims Act Working Group

    Aug 15, 202513 minS2

    <p>In this episode, Alan Minsk, AGG Food & Drug practice chair and Life Sciences co-chair, and Brian Stimson, co-chair of the Healthcare practice and former acting general counsel and principal deputy general counsel of...

  • Episode #9

    Tell Me Lies, Tell Me Sweet Little Lies: FDA Is Not My Only Potential Headache When It Comes to Product Promotion

    Mar 23, 202329 minS1

    <p>In this episode, Alan G. Minsk, AGG Food & Drug team leader, and Anuj Desai, AGG Intellectual Property partner and head of Trademarks, discuss recent developments that remind our audience in the food and drug space...

View More
  • Episode #8

    Business Divorces in the Food and Supplements Space

    Sep 27, 202123 minS1

    <p>In this episode, Michael E. Burke, partner and co-chair of the Pharmaceutical & Biotechnology industry team is joined by Robert Durkin, an attorney in our Dietary Supplements team, as they discuss issues around...

  • AGG Talks: Government Insight for Life Sciences Leaders Podcast Series

    Fee Waivers for Small Businesses: Who Qualifies for the Small Business User Fee Waiver for Drugs and Biologics and How to Apply from an FDA and Corporate Perspective

    Jun 29, 202113 minS0

    <p>In this episode, AGG’s Food & Drug team leader, Alan G. Minsk, and Genevieve M. Razick, an attorney in our Healthcare and Food & Drug practices, along with Leah D. Braukman, an attorney in our Corporate & Finance...

  • Episode #6

    Data Privacy Issues Life Sciences Companies May Encounter

    Mar 1, 202120 minS1

    <p>In this episode, AGG’s Food & Drug team leader, Alan G. Minsk, and co-chair of AGG’s Data Privacy practice, Kevin L. Coy, discuss U.S. and international privacy and data security law issues life sciences companies...

  • Episode #5

    FDA Regulation of Rx Drug and Medical Device Advertising and Promotion: 2020 Year in Review

    Feb 1, 202121 minS1

    <p>In this episode, AGG’s Food & Drug team leader, Alan G. Minsk, and team member, Genevieve M. Razick, give an overview of FDA’s Office of Prescription Drug Promotion’s (OPDP) enforcement of unlawful advertising in...

  • Episode #4

    FDA Regulated Natural Products: Leveraging IP and Regulatory Requirements to Maximize Possible Return on Investment

    Jan 1, 202140 minS1

    <p>In this episode, partner Kevin M. Bell and of counsel Bob Durkin discuss some of the more interesting issues and challenges they have encountered when working with clients to ensure they maximized opportunities to...

  • Episode #3

    Pandemic Marketing 101: Do’s and Don’ts to Market Your Brands, Products, and Services Safely

    Dec 1, 202029 minS1

    <p>In this episode, partner Anuj Desai and of counsel Carolina M. Wirth discuss the Federal Trade Commission (FTC) and Food and Drug Administration's (FDA) roles of protecting consumers at the height of a public health...

  • Episode #2

    Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products

    Nov 1, 202025 minS1

    <p>In this episode, Alan G. Minsk, partner and leader of the Food & Drug practice team, is joined by Brian A. Teras, partner of the Corporate & Securities practice team. They provide an overview of the diligence...

  • Episode #1

    Quality Agreements for FDA-Regulated Products: Looking Under the Hood

    Oct 1, 202027 minS1

    <p>In our inaugural episode, Alan G. Minsk, partner and leader of the Food & Drug practice team, is joined by Michael E. Burke, co-chair of the Pharmaceuticals & Biologics industry team. They discuss issues around...

Guest Appearances

Recent guests on AGG Talks: Government Insight for Life Sciences Leaders Podcast Series. Study who booked and why before you pitch.

Best industries to pitch AGG Talks: Government Insight for Life Sciences Leaders Podcast Series for

PitchCentric classifies AGG Talks: Government Insight for Life Sciences Leaders Podcast Series under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.

Podcasts like AGG Talks: Government Insight for Life Sciences Leaders Podcast Series

Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.

Questions about the free trial? See the pricing FAQ